Analyst Ratings for Day One Biopharmaceuticals (DAWN)
DAWN Rating Summary
DAWN Price Target Summary
- Highest: $27.00 (JPMorgan)
- Lowest: $21.50 (TD Cowen)
- Average: $22.70
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$22.70 (+7.1%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
Avg. $ Target:
$22.70 (+7.1%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | TD Cowen | Tara Bancroft | Downgrade | Hold (Buy) |
21.50 (24.00) |
12.78 (21.20) |
65.88% | Details |
| 3/6/2026 | Needham | Ami Fadia | Downgrade | Hold (Buy) |
N/A (N/A) |
12.78 (21.20) |
65.88% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
